Tag: Phase 2 study
November 25, 2019
CymaBay Therapeutics Stops Clinical Development of Seladelpar
The company announced it is terminating a Phase 2b study, a Phase 2 study and putting on hold seladelpar in... November 12, 2019
Aptinyx Begins Two Phase 2 Studies of NYX-2925
The company is evaluating its NYX-2925 treatment in painful diabetic peripheral neuropathy and fibromyalgia. April 3, 2019
BELLUS Health Receives Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients
BELLUS Health ((TSX:BLU) has announced that the US Food and Drug Administration (FDA) has accepted Bellus’ investigational new drug (IND)... April 2, 2019
NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019
NewLink Genetics (NASDAQ:NLNK) has announced results from its Phase 2 study of NLG207, a nanoparticle of the topoisomerase 1 inhibitor... December 4, 2018
Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study
Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition... May 8, 2018
Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
Zynerba Pharmaceuticals (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare...
April 29, 2018